Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

549.76 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Sep 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9
...
47 48 Next >
Market Rally On The Ropes, AI Stocks Tumble: Weekly Review
The Nasdaq fell below its 50-day moving average. 
Via Investor's Business Daily
Topics Artificial Intelligence
Exposures Artificial Intelligence
Ex-Fund Manager Regrets Missing The Boat On A Stock Which Rallied 16% This Week: 'I Should Have Followed My Instincts'
Whitney Tilson recalled his comments in late-2022 about 'miraculous' weight-loss drugs and said he regretted not buying Eli Lilly stock then. 
Via Benzinga
Expert Ratings for Eli Lilly
Via Benzinga
Obesity Drug Wegovy Sales Jump 365% In H1 As Novo Nordisk Reports Solid Results, Raises FY23 Guidance
Via Benzinga
Looking At Eli Lilly's Recent Unusual Options Activity
Via Benzinga
Eli Lilly Stock Is A ‘Buy’ After Its Blockbuster Q2
Eli Lilly stock has already gained about 45% year-to-date. 
Via Talk Markets
Eli Lilly (LLY) Q2 2023 Earnings Call Transcript
LLY earnings call for the period ending June 30, 2023. 
Via The Motley Fool
3 Growth Stocks to Sell in August Before They Crash and Burn
Smart investors are proceeding cautiously with these securities either suffering a pullback or in danger of one. 
Via InvestorPlace
65% Profit On Eli Lilly — 20% Reduction In Heart Attacks And Strokes With Weight Loss Drug — Raising The Target
Signal Limited is a Signal(s) with a great record in similar situations but does not meet all of the stringent criteria for a Signal. Typically Signal Limited has higher risk-reward compared to a... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2023
Via Benzinga
Indomitable Eli
Eli Lilly came out with earnings this morning, thrusting the stock to yet another lifetime high. 
Via Talk Markets
Eli Lilly Q2 Earnings And Revenues Top Estimates
Eli Lilly came out with quarterly earnings of $2.11 per share. 
Via Talk Markets
Zoetis Stock Slides As Rough Sales Outlook Chips Away At Quarterly Beat
Zoetis also raised its earnings outlook for the year. But shares dipped early Tuesday. 
Via Investor's Business Daily
Eli Lilly Analysts Bump Up Forecasts On Q2 Print: 'Beyond Mounjaro, Alzheimer's Franchise Remains A Key Pillar To Future Growth'
Shares of Eli Lilly And Co (NYSE: LLY) Tuesday spiked, after the company reported strong second-quarter results. 
Via Benzinga
After This Pharma Stock Surges To Record High, Cramer Says It's 'Going Higher Still'
Eli Lilly reported a beat-and-raise Q2 on Tuesday and its stock moving into record territory and Cramer thinks there is more upside to it. 
Via Benzinga
Eli Lilly Has A Big Stake In Weight Loss And Alzheimer's Drugs; But Is The Stock A Buy?
Lilly shares surged 15% in one day to a record high. Here's what you should know. 
Via Investor's Business Daily
CBOE Volatility Index Increases Ahead Of Inflation Data
The S&P 500 settled lower on Tuesday, after credit rating agency Moody's downgraded 10 small- to mid-sized lenders. The S&P 500 Banks index has lost 2.5% year-to-date, versus a 17.2% surge recorded by... 
Via Benzinga
Earnings Surprises And Inflation Still In Play: Your Midweek Market Update
We had a surprise 15% gain in Eli Lilly on earnings today and we're gearing up for Disney's earnings tomorrow. 
Via Talk Markets
Lilly Stock Rockets After Diabetes Powerhouse Mounjaro Drives Beat And Raise
Eli Lilly also raised its outlook for full-year adjusted earnings and sales. 
Via Investor's Business Daily
Wegovy, Ozempic Could Save 139,400 Lives In US Each Year; Novo Nordisk Heart Attack Research Reveals New Benefits
Via Benzinga
Eli Lilly (LLY) Stock Just Reached a New All-Time High
Pharma giant Eli Lilly saw LLY stock reach record heights as the company posted strong Q2 results, undergirded by a key diabetes drug. 
Via InvestorPlace
Moody's Downgrades Hits Banks, But Health Care Glows As Lilly, Novo Nordisk Boosted By Earnings, Data
(Tuesday market open) Several months after the opening salvo, regional banks came back into focus Tuesday morning after Moody’s cut ratings on several of them and warned that more downgrades might be... 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Dow Falls 1%; Eli Lilly Raises Annual Guidance
U.S. stocks were lower midway through trading, with the Dow Jones falling over 1% on Tuesday. The Dow traded down 1.05% to 35,099.88 while the NASDAQ fell 1.47% to 13,788.21. The S&P 500, also fell,... 
Via Benzinga
Why Energizer Holdings Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 185.6% to $1.6593 after the company announced contract with NASA to demonstrate feasibility of power beaming in space using the company’s blue laser... 
Via Benzinga
Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Are On Fire Today
Novo Nordisk's popular weight loss drug also confers a significant cardioprotective effect, according to a new study. 
Via The Motley Fool
Fox, Warner Music, Eli Lilly, Chegg And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Dow Jones falling around 400 points on Tuesday. Here are some big stocks recording gains in today’s session. Paymentus Holdings, Inc. (NYSE: PAY) shares rose 29.4% to... 
Via Benzinga
Weight Loss Drug Maker Eli Lilly Stock Soars Amid Mounjaro Sales, Diabetes Treatment In Second Quarter
Eli Lilly And Co (NYSE: LLY) has reported Q2 sales of $$8.31 billion, up 28% Y/Y, beating the consensus of $7.58 billion, d 
Via Benzinga
Eli Lilly Set To Report Earnings: $7.5B In Revenue Expected, Options Market Implies 4.5% Move
Eli Lilly and Company (NYSE: LLY) is scheduled to release quarterly earnings results before the opening bell on Aug. 8, 2023. 
Via Benzinga
Small-Cap Slide Ahead? US Stocks Set For Weaker Open On Inflation Anxiety: Analysts Warn 'Mild' Recession Still Likely
The earnings news flow will likely be the driver of the market, given the absence of any market-moving economic data. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
47 48 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.